Evidence map›Paper›PMID 41164156›Full record

ArticleDigital health

Implementing the SAFE@home digital platform for blood pressure home monitoring for patients with (a risk of) hypertensive disorders of pregnancy: A barrier and facilitator analysis among obstetric healthcare professionals.

Shinta L Moes, Martine Depmann, Kvamme Ingelin, Elles In 't Anker, Jacques Dirken, Leonoor Van Eerden, Arie Franx, Roel De Heus, Sanne J Gordijn, Steven Koenen and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shinta L MoesDepartment of Obstetrics and Gynecology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-1385-8773
Martine DepmannDepartment of Obstetrics and Gynecology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Kvamme IngelinJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Elles In 't AnkerDepartment of Obstetrics and Gynecology, Bravis Hospital, Bergen op Zoom, The Netherlands.
Jacques DirkenDepartment of Obstetrics and Gynecology, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands.
Leonoor Van EerdenDepartment of Obstetrics and Gynecology, Maasstad Hospital, Rotterdam, The Netherlands.
Arie FranxDepartment of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands.
Roel De HeusDepartment of Obstetrics and Gynecology, St Antonius Hospital, Nieuwegein, The Netherlands.
Sanne J GordijnDepartment of Obstetrics and Gynecology, University Medical Center Groningen, Groningen, The Netherlands.
Steven KoenenDepartment of Obstetrics and Gynecology, Elisabeth Tweesteden Hospital/Fam, Tilburg, The Netherlands.
Maarten Mh LahrDepartment of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.
Titia A LelyDepartment of Obstetrics and Gynecology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Flip Van Der MadeDepartment of Obstetrics and Gynecology, St Franciscus Gasthuis Hospital, Rotterdam, The Netherlands.
Lindy SantegoetsDepartment of Obstetrics and Gynecology, Reinier de Graaf Hospital, Delft, The Netherlands.
Marc SpaandermanDepartment of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands.
Ewoud SchuitJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Mireille N BekkerDepartment of Obstetrics and Gynecology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hypertensive disorders of pregnancy complicate at least 10% of pregnancies, and are associated with fetomaternal morbidity and mortality. Traditional management is resource-intensive. Remote monitoring offers a safe and patient friendly alternative to managing hypertensive disorders. However, scaling telemonitoring requires understanding of implementation facilitators and barriers. This study explores the implementation of SAFE@home, a platform for monitoring blood pressure and symptoms, among obstetric healthcare professionals (OHPs). Material and methods: An implementation study was conducted across 11 Dutch hospitals from November 2020 to December 2023, evaluating implementation of a home-monitoring platform for pregnant women with a high risk of or with established hypertensive disorders. Implementation outcomes were evaluated using Proctor's taxonomy, Normalization Measurement Development and Measurement Instrument for Determinants of Innovations questionnaires, platform, and electronic health records data. OHPs received questionnaires at the start of implementation ( Results: Of 133 OHPs, 83 (62.4%) and 101 (75.9%) responded to Conclusions: SAFE@home was successfully implemented, with high acceptance and sustainability potential. While time constraints and initial uncertainty were barriers, most OHPs believed telemonitoring could improve care for high-risk pregnancies.

Indexed as

blood pressuredigital healthhealthcare professionalImplementationobstetricstelemonitor

Identifiers

PMID41164156
PMCPMC12559661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.